Aviado Bio
At AviadoBio, our mission is to develop and deliver potentially transformative gene therapies for people living with devastating neurodegenerative diseases such as frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS).
With our deep understanding of the brain and our suite of proprietary gene therapy platforms and delivery technologies, we are working relentlessly to overcome the challenges of delivering the right drug to the right place. Our innovative, neuroanatomy-led approach is designed to maximize the therapeutic potential of gene therapy to potentially halt or potentially even reverse neurodegenerative diseases.
AviadoBio is focused on targeted and precise drug delivery and dosing for maximal biodistribution to the brain and spinal cord with a favorable safety profile. We believe delivery to be the game changer in overcoming challenges with existing treatment pathways.